$85.68
3.85% yesterday
NYSE, Sep 11, 10:00 pm CET

PerkinElmer Stock price

$85.68
-0.12 0.14% 1M
-27.24 24.12% 6M
-25.93 23.23% YTD
-35.33 29.20% 1Y
-56.69 39.82% 3Y
-32.01 27.20% 5Y
+37.74 78.72% 10Y
+64.76 309.56% 20Y
NYSE, Closing price Thu, Sep 11 2025
+3.18 3.85%

Key metrics

Basic
Market capitalization
$9.9b
Enterprise Value
$12.2b
Net debt
$2.2b
Cash
$991.9m
Shares outstanding
116.3m
Valuation (TTM | estimate)
P/E
35.4 | 17.2
P/S
3.6 | 3.4
EV/Sales
4.4 | 4.2
EV/FCF
24.2
P/B
1.3
Dividends
DPS
$0.28
Yield 1Y | 5Y
0.3% | 0.2%
Growth 1Y | 5Y
0.0% | 0.0%
Payout 1Y | 3Y
12.7% | 6.9%
Increased
0 Years
Financials (TTM | estimate)
Revenue
$2.8b | $2.9b
EBITDA
$812.7m | $873.7m
EBIT
$399.8m | $791.8m
Net Income
$285.2m | $578.4m
Free Cash Flow
$503.0m
Growth (TTM | estimate)
Revenue
3.3% | 5.6%
EBITDA
1.9% | 2.9%
EBIT
8.4% | 88.0%
Net Income
68.3% | 113.9%
Free Cash Flow
31.3%
Margin (TTM | estimate)
Gross
55.9%
EBITDA
29.0% | 30.0%
EBIT
14.3%
Net
10.2% | 19.9%
Free Cash Flow
18.0%
Financial Health
Equity Ratio
61.9%
Return on Equity
3.5%
ROCE
3.4%
ROIC
-
Debt/Equity
0.4
More
EPS
$2.4
FCF per Share
$4.3
Short interest
7.6%
Employees
11k
Rev per Employee
$250.0k
Show more

Is PerkinElmer a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,008 stocks worldwide.

PerkinElmer Stock Analysis

Unlock Scores for Free

Analyst Opinions

26 Analysts have issued a PerkinElmer forecast:

17x Buy
65%
8x Hold
31%
1x Sell
4%

Analyst Opinions

26 Analysts have issued a PerkinElmer forecast:

Buy
65%
Hold
31%
Sell
4%

Financial data from PerkinElmer

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
2,798 2,798
3% 3%
100%
- Direct Costs 1,233 1,233
2% 2%
44%
1,565 1,565
5% 5%
56%
- Selling and Administrative Expenses 965 965
5% 5%
34%
- Research and Development Expense 205 205
2% 2%
7%
813 813
2% 2%
29%
- Depreciation and Amortization 413 413
4% 4%
15%
EBIT (Operating Income) EBIT 400 400
8% 8%
14%
Net Profit 285 285
68% 68%
10%

In millions USD.

Don't miss a Thing! We will send you all news about PerkinElmer directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

PerkinElmer Stock News

Neutral
Seeking Alpha
3 days ago
Revvity, Inc. (NYSE:RVTY ) Baird 2025 Global Healthcare Conference September 9, 2025 2:35 PM EDT Company Participants Stephen Willoughby - Senior VP of Investor Relations & Head of ESG Conference Call Participants Catherine Ramsey - Robert W. Baird & Co. Incorporated, Research Division Presentation Catherine Ramsey Senior Research Analyst Go ahead and get started here.
Neutral
Seeking Alpha
9 days ago
Revvity, Inc. (NYSE:RVTY ) Wells Fargo 20th Annual Healthcare Conference 2025 September 3, 2025 8:00 AM EDT Company Participants Maxwell Krakowiak - Senior VP & CFO Conference Call Participants Brandon Couillard - Wells Fargo Securities, LLC, Research Division Presentation Brandon Couillard MD & Equity Analyst All right. Good morning.
Neutral
Business Wire
10 days ago
WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today announced the opening of its new In Vivo Imaging Center of Excellence in Morrisville, North Carolina, the heart of the state's Research Triangle. The center consolidates Revvity's expertise and resources to drive R&D innovation and create the next generation of imaging systems backed by AI software tools and other advanced techn...
More PerkinElmer News

Company Profile

PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. It operates through the following segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment comprises of technologies that help life sciences researchers better understand diseases and develop treatments. The Diagnostics segment offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals to help improve the health of families. The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937 and is headquartered in Waltham, MA.

Head office United States
CEO Prahlad Singh
Employees 11,000
Founded 1937
Website www.revvity.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today